ERBB4 contributes to parathyroid cell dysfunction and progression of secondary hyperparathyroidism

Secondary hyperparathyroidism (SHPT) is a frequent complication of chronic kidney disease (CKD), manifested by parathyroid hyperplasia and excessive parathyroid hormone (PTH) secretion. However, the regulatory mechanisms governing SHPT progression remain incompletely understood. To explore the molecular mechanisms underlying CKD-associated SHPT, we generated single-nucleus RNA-seq (snRNA-seq) profiles of parathyroid tissues from SHPT patients and control subjects to establish the transcriptional landscape comparing human normal and SHPT parathyroid glands. Pseudotime trajectory analysis revealed progressive enrichment of the ERBB signaling pathway along trajectories leading toward terminal cell states during parathyroid cell differentiation. Multiple RNA-seq datasets, including bulk transcriptomic data and publicly available transcriptomic data, were integrated to facilitate candidate gene screening. Integrated transcriptomic analyses identified ERBB4 as a markedly upregulated gene in parathyroid tissues from patients with SHPT, with particularly high expression in oxyphil cells. Subsequent analyses of snRNA-seq data confirmed robust activation of ERBB signaling in SHPT parathyroid tissues. Immunohistochemistry (IHC) further confirmed elevated ERBB4 protein levels in parathyroid tissues from uremic patients with SHPT. In vitro experiments using SHPT patient-derived primary parathyroid cells demonstrated that inhibition of ERBB4 or ERBB signaling suppressed parathyroid cell proliferation and reduced PTH secretion. Collectively, this study generates high-resolution transcriptomic profiles of human SHPT parathyroid tissues, delineates key cellular pathological features at single-nucleus resolution, and identifies ERBB4 as a potential contributor to parathyroid gland hyperfunction in CKD-related SHPT.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-18
DOI
https://doi.org/10.3389/fcell.2026.1878179
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ERBB4 contributes to parathyroid cell dysfunction and progression of secondary hyperparathyroidism

Lulin Ji, Zhongliang Hu
Frontiers in Cell and Developmental Biology
Parathyroid Disorders and Treatments
article

ERBB4 contributes to parathyroid cell dysfunction and progression of secondary hyperparathyroidism

Lulin Ji, Zhongliang Hu
article en

Abstract

Secondary hyperparathyroidism (SHPT) is a frequent complication of chronic kidney disease (CKD), manifested by parathyroid hyperplasia and excessive parathyroid hormone (PTH) secretion. However, the regulatory mechanisms governing SHPT progression remain incompletely understood. To explore the molecular mechanisms underlying CKD-associated SHPT, we generated single-nucleus RNA-seq (snRNA-seq) profiles of parathyroid tissues from SHPT patients and control subjects to establish the transcriptional landscape comparing human normal and SHPT parathyroid glands. Pseudotime trajectory analysis revealed progressive enrichment of the ERBB signaling pathway along trajectories leading toward terminal cell states during parathyroid cell differentiation. Multiple RNA-seq datasets, including bulk transcriptomic data and publicly available transcriptomic data, were integrated to facilitate candidate gene screening. Integrated transcriptomic analyses identified ERBB4 as a markedly upregulated gene in parathyroid tissues from patients with SHPT, with particularly high expression in oxyphil cells. Subsequent analyses of snRNA-seq data confirmed robust activation of ERBB signaling in SHPT parathyroid tissues. Immunohistochemistry (IHC) further confirmed elevated ERBB4 protein levels in parathyroid tissues from uremic patients with SHPT. In vitro experiments using SHPT patient-derived primary parathyroid cells demonstrated that inhibition of ERBB4 or ERBB signaling suppressed parathyroid cell proliferation and reduced PTH secretion. Collectively, this study generates high-resolution transcriptomic profiles of human SHPT parathyroid tissues, delineates key cellular pathological features at single-nucleus resolution, and identifies ERBB4 as a potential contributor to parathyroid gland hyperfunction in CKD-related SHPT.

Frontiers in Cell and Developmental BiologyVol. 14
Central South University (CN)
Good health and well-being
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon